Zobrazeno 1 - 4
of 4
pro vyhledávání: ''
Autor:
Kazunari Tanabe, Kazuya Omoto, Hiroki Ishihara, Kohei Unagami, Tomokazu Shimizu, Toshihito Hirai, Masayoshi Okumi, Hideki Ishida
Publikováno v:
Transplantation. 101(6):1423-1432
Background In ABO-incompatible kidney transplantation, the diagnostic criteria for antibody-mediated rejection remain controversial because C4d deposition is commonly observed. Thus, we investigated microvascular inflammation (MVI score ≥ 2) within
Autor:
Nicolaas A. Bakker, Michiel E. Erasmus, Erik A M Verschuuren, Cees G. M. Kallenberg, Wim van der Bij, Bouke G. Hepkema, Nic J. G. M. Veeger
Publikováno v:
Transplantation, 83(4), 433-438. LIPPINCOTT WILLIAMS & WILKINS
Background. Posttransplant lymphoproliferative disease (PTLD) is a serious complication after lung transplantation and its relation with Epstein-Barr virus (EBV) is well recognized. It has been postulated that preemptive reduction of immunosuppressio
Autor:
Joke I. Roodnat, Cecile T.J. Holweg, Carla C. Baan, Willem Weimar, Aggie H.M.M. Balk, Jacqueline van de Wetering, Charlotte H. E. Weimar, Ron T. van Domburg
Publikováno v:
Transplantation, 82(12), 1744-1748. Lippincott Williams & Wilkins
BACKGROUND: Nephrotoxicity is a major side effect of calcineurin inhibitors (CNI). Earlier we reported 8% of our heart transplant recipients reaching end-stage renal failure (ESRF). Now, with an extended follow up of 20 years, we re-evaluated the dev
Autor:
Leszek Paczek, Josep M. Grinyó, A Jurewicz, Georges Mourad, Yves Vanrenterghem, Henri Kreis, Zbigniew Wlodarczyk, LC Paul, Marian Klinger, Jean-Paul Squifflet, C Short, R Chang, J.P. van Hooff, Peter Neuhaus, Lionel Rostaing, Bernard Charpentier
Publikováno v:
Transplantation, 78(1), 9-14. LIPPINCOTT WILLIAMS & WILKINS
The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients.Vanrenterghem Y, van Hooff JP, Klinger M, Wlodarczyk Z, Squifflet JP, Mourad G, Neuhaus P, Jurewicz A, Rostaing L, Charpentier